Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer
Clinical trial NCT03900884 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03900884
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-25
- Primary completion
- 2025-06-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.